BRAF and cutaneous melanoma: For cutaneous melanoma, it was previously shown that NRAS mutations are associated with shorter distant metastasis-free survival compared to BRAF mutated patients, but there is no difference between NRAS mutated and BRAF/NRAS WT patients [25].